Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States.
$1.26-3.82%
报价 2026-11-16
市值
$135M
EV
$113.6M
PE (TTM)
–
预期 PE (FY2026)
6.8x
52 周区间距高点 -56.1%
$0.63$2.87
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| DHDefinitive Healthcare Corp. | $135M | -3.8% | -6.7% | 71.7% | – | – | 4.1x | |
| SOPHSOPHiA GENETICS S.A. | $633.4M | -9.4% | – | 67.3% | – | – | – | |
| NRCNational Research Corporation | $558.8M | -0.9% | +6.5% | 47.9% | 89.5x | 28.5x | 32.5x | |
| KYTXKyverna Therapeutics, Inc. | $300.9M | -5.7% | +86.6% | 0% | – | – | – | |
| EDITEditas Medicine, Inc. | $288.6M | -13.8% | +27.8% | 56.9% | – | – | – | |
| SPOKSpok Holdings, Inc. | $245.4M | +0.7% | -0.9% | 88.5% | 13.2x | 7.1x | 8.2x | |
| CABACabaletta Bio, Inc. | $239.4M | -13.3% | -43.2% | 0% | – | – | – | |
| NAKANakamoto Inc. | $79.9M | -8.2% | +2488.9% | 14.2% | – | – | – | |
| 同行中位数 | – | – | +17.1% | 47.9% | 51.3x | 17.8x | 20.3x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。